Search research articles
Contact Us
Filters
Showing results (1351-1360 of 1,406) with videos related to
Page
of 141
Sort By:
Cancer Research
|
February 28, 2001
In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B
M J Towle, K A Salvato, J Budrow, et al.
Nature Methods
|
June 23, 2006
Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays
Peter J Sabo, Michael S Kuehn, Robert Thurman, et al.
Nature Communications
|
October 30, 2025
Upcycling waste polystyrene to adipic acid through a hybrid chemical and biological process
Hyunjin Moon, Jason S DesVeaux, Elisabeth C Van Roijen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 31, 2023
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
Barry A Singer, Douglas L Arnold, Jelena Drulovic, et al.
Stroke (Hoboken, N.J.)
|
January 23, 2026
Intraprocedural Technical Events During Flow Diverter Implantation Partially Mediate the Effect of Age on Aneurysm Occlusion
Juan Vivanco-Suarez, Aaron Rodriguez-Calienes, Yujing Lu, et al.
Eye (London, England)
|
May 12, 2023
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results
Arshad M Khanani, Aamir A Aziz, Hannah Khan, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors
Caroline E Wheeler, Samuel S Coleman, Rebecca Hoyd, et al.
Urologic Oncology
|
August 8, 2025
Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer
Matthew Ho, Alon Lazarovich, Ragheed Saoud, et al.
The Lancet. Oncology
|
May 13, 2024
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
Andrea Necchi, Mathieu Roumiguié, Ashish M Kamat, et al.
Science (New York, N.Y.)
|
September 10, 2016
Improving the forecast for biodiversity under climate change
M C Urban, G Bocedi, A P Hendry, et al.
Page
of 141
Search research articles
Search
Showing results (1351-1360 of 1,406) with videos related to
Sort By:
Page
of 141
Cancer Research
|
February 28, 2001
In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B
M J Towle, K A Salvato, J Budrow, et al.
Nature Methods
|
June 23, 2006
Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays
Peter J Sabo, Michael S Kuehn, Robert Thurman, et al.
Nature Communications
|
October 30, 2025
Upcycling waste polystyrene to adipic acid through a hybrid chemical and biological process
Hyunjin Moon, Jason S DesVeaux, Elisabeth C Van Roijen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 31, 2023
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study
Barry A Singer, Douglas L Arnold, Jelena Drulovic, et al.
Stroke (Hoboken, N.J.)
|
January 23, 2026
Intraprocedural Technical Events During Flow Diverter Implantation Partially Mediate the Effect of Age on Aneurysm Occlusion
Juan Vivanco-Suarez, Aaron Rodriguez-Calienes, Yujing Lu, et al.
Eye (London, England)
|
May 12, 2023
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results
Arshad M Khanani, Aamir A Aziz, Hannah Khan, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors
Caroline E Wheeler, Samuel S Coleman, Rebecca Hoyd, et al.
Urologic Oncology
|
August 8, 2025
Bacillus Calmette-Guérin (BCG) in combination with PANVAC™ vs. BCG alone in adults with high-grade BCG-refractory non-muscle-invasive bladder cancer
Matthew Ho, Alon Lazarovich, Ragheed Saoud, et al.
The Lancet. Oncology
|
May 13, 2024
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
Andrea Necchi, Mathieu Roumiguié, Ashish M Kamat, et al.
Science (New York, N.Y.)
|
September 10, 2016
Improving the forecast for biodiversity under climate change
M C Urban, G Bocedi, A P Hendry, et al.
Page
of 141